CHESTNUT HILL, MA – March 09, 2026 – PRESSADVANTAGE – ...

Hims & Hers shares jumped more than 50% in premarket trade on Monday after ending a dispute with Novo Nordisk by striking a ...

New platform connects patients with licensed providers offering sermorelin under medical supervision, supported by a growing body of peer-reviewed research and an emerging community of clinicians and ...

Novo Nordisk struck another deal with Hims & Hers. Hims & Hers shares opened more than 40% on Monday after the company ended a dispute with Novo Nordisk and struck another partnership with the Danish ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...

Developers of gene therapies to treat knee osteoarthritis are taking the familiar intra-articular route to deliver proteins and molecules directly to the site of the disease.

How Long It Lasts and Tips to Reduce It This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Nausea is the most ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY (piflufolastat F 18) with the potential for larger batches and greater pati ...

A training company that teaches medical providers how to perform cosmetic injections has partnered with the UNC School of Nursing in Chapel Hill to offer hands-on instruction in Botox and dermal ...

The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate cancer, according to an industry press release. As Healio previously reported, ...

Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to a manageable lifetime condition for those who are successfully being treated.Initially, ...

Hangzhou Sciwind Biosciences Co., Ltd. ('Sciwind'), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic diseases, announced today that China's ...